Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 01, 2015 2:22 AM ET

Biotechnology

Company Overview of Institut Mérieux SA

Company Overview

Institut Mérieux SA, through its subsidiaries, develops solutions in the fields of diagnostics, immunotherapy, food safety, and nutrition to treat infectious diseases, cancers, and metabolic disorders. The company develops and sells in vitro diagnostic solutions for medical and industrial applications; and designs and develops therapeutic vaccines and immunotherapy products to treat cancers and infectious diseases. It also develops, produces, and distributes systems and reagents for in vitro diagnosis that are used by monitoring laboratories for microbiological quality control in agri-food, pharmaceutical, and cosmetics industries; and provides biological and chemical analyses, research and ...

17 Rue Bourgelat

Lyon,  69002

France

Founded in 1897

Phone:

33 4 78 87 70 70

Fax:

33 4 78 87 70 71

Key Executives for Institut Mérieux SA

Chief Financial Officer
Age: 58
Communications Director
Director General Delegate
Public Affairs Director
Vice President of Medical and Scientific Affairs
Compensation as of Fiscal Year 2015.

Institut Mérieux SA Key Developments

Institut Mérieux Announces Executive Changes, Effective October 1, 2013

Dr. Marc Bonneville has been appointed Vice-President in charge of Medical and Scientific Affairs at Institut Mérieux. Starting October 1, 2013, he will be taking over from Prof. Christian Bréchot, who has been called upon to lead the Institut Pasteur. Dr. Bonneville will be responsible for pursuing and expanding the activities instigated by Prof. Bréchot, in particular with respect to the Mérieux Research Grants program, multidisciplinary research projects, and various joint activities between the group's companies at an international level. Dr. Bonneville is co-founder and member of scientific advisory boards for various companies in the field of biotechnology and healthcare and has extensive experience of industrial partnerships.

Similar Private Companies By Industry

Company Name Region
Atlantic Bone Screen Company Europe
Neurotech S.A. Europe
Prestagen S.A. Europe
Pherecydes Pharma SA Europe
Sequentia Europe

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
January 16, 2015
Decitre Interactive SAS
Private Placement
January 13, 2015
NeoMedLight SAS
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Institut Mérieux SA, please visit www.institut-merieux.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.